Pages that link to "Q45204007"

The following pages link to Antibody-targeted polymer-doxorubicin conjugates with pH-controlled activation (Q45204007):

Displaying 22 items.

• Traceless bioresponsive shielding of adenovirus hexon with HPMA copolymers maintains transduction capacity in vitro and in vivo (Q28539158) (← links)
• Optical imaging-guided cancer therapy with fluorescent nanoparticles (Q33731037) (← links)
• Synthesis of a covalent epirubicin-(C(3)-amide)-anti-HER2/neu immunochemotherapeutic utilizing a UV-photoactivated anthracycline intermediate (Q35180943) (← links)
• Utilization of monoclonal antibody-targeted nanomaterials in the treatment of cancer (Q35578037) (← links)
• Epirubicin-[Anti-HER2/neu] Synthesized with an Epirubicin-(C13-imino)-EMCS Analog: Anti-Neoplastic Activity against Chemotherapeutic-Resistant SKBr-3 Mammary Carcinoma in Combination with Organic Selenium (Q35896698) (← links)
• Targeting of multidrug-resistant human ovarian carcinoma cells with anti-P-glycoprotein antibody conjugates (Q36185372) (← links)
• Antibody-cytotoxic agent conjugates for cancer therapy (Q36316831) (← links)
• Cellular delivery of doxorubicin via pH-controlled hydrazone linkage using multifunctional nano vehicle based on poly(β-l-malic acid) (Q36321843) (← links)
• Recent advances in nanoparticle-based Förster resonance energy transfer for biosensing, molecular imaging and drug release profiling (Q36538483) (← links)
• HPMA Copolymer-Drug Conjugates with Controlled Tumor-Specific Drug Release (Q38626421) (← links)
• Antibody-targeted biodegradable nanoparticles for cancer therapy (Q38665261) (← links)
• Anti-Lymphoma Efficacy Comparison of Anti-Cd20 Monoclonal Antibody-Targeted and Non-Targeted Star-Shaped Polymer-Prodrug Conjugates. (Q38820373) (← links)
• HPMA copolymer conjugates of DOX and mitomycin C for combination therapy: physicochemical characterization, cytotoxic effects, combination index analysis, and anti-tumor efficacy (Q39096548) (← links)
• RAFT-derived polymer-drug conjugates: poly(hydroxypropyl methacrylamide) (HPMA)-7-ethyl-10-hydroxycamptothecin (SN-38) conjugates (Q39432578) (← links)
• Preclinical evaluation of linear HPMA-doxorubicin conjugates with pH-sensitive drug release: efficacy, safety, and immunomodulating activity in murine model (Q39778453) (← links)
• Peptide-targeted polyglutamic acid doxorubicin conjugates for the treatment of alpha(v)beta(6)-positive cancers (Q39949731) (← links)
• HPMA based macromolecular therapeutics: internalization, intracellular pathway and cell death depend on the character of covalent bond between the drug and the peptidic spacer and also on spacer composition (Q40210611) (← links)
• Biodegradable star HPMA polymer conjugates of doxorubicin for passive tumor targeting (Q44991152) (← links)
• Core-shell poly(lactide-co-ε-caprolactone)-gelatin fiber scaffolds as pH-sensitive drug delivery systems (Q47204191) (← links)
• A tumor-targeted polymer theranostics platform for positron emission tomography and fluorescence imaging (Q48088727) (← links)
• Molecular Mechanisms of the Interactions of N-(2-Hydroxypropyl)methacrylamide Copolymers Designed for Cancer Therapy with Blood Plasma Proteins (Q89510832) (← links)
• High-affinity mutant Interleukin-13 targeted CAR T cells enhance delivery of clickable biodegradable fluorescent nanoparticles to glioblastoma (Q94673512) (← links)